Abstract
Single-use systems (also referred to as disposables) have become a huge part of the bioprocessing industry, which raised concern in the industry regarding quality and security of supply. Processes must be in place to assure the supply and control of outsourced activities and quality of purchased materials along the product life cycle. Quality and security of supply for single-use bioreactors (SUBs) are based on a multidisciplinary approach. Developing a state-of-the-art SUB-system based on quality by design (QbD) principles requires broad expertise and know-how including the cell culture application, polymer chemistry, regulatory requirements, and a deep understanding of the biopharmaceutical industry. Using standardized products reduces the complexity and strengthens the robustness of the supply chain. Well-established supplier relations including risk mitigation strategies are the basis for achieving long-term security of supply. Well-developed quality systems including change control approaches aligned with the requirements of the biopharmaceutical industry are a key factor in supporting long-term product availability. This chapter outlines the approach to security of supply for key materials used in single-use production processes for biopharmaceuticals from a supplier perspective.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- CPP:
-
Critical process parameter
- CQA:
-
Critical quality attribute
- DoE:
-
Design of experiments
- EP:
-
European pharmacopeia
- FDA:
-
Food and Drug Administration
- FMEA:
-
Failure mode effect analysis
- GMP:
-
Good manufacturing practice
- ICH:
-
International Committee Harmonization
- LLDPE:
-
Linear low-density polyethylene
- PAT:
-
Process analytical technology
- PE:
-
Polyethylene
- QbD:
-
Quality by design
- SUB:
-
Single-use bioreactor
- URS:
-
User requirements specifications
- USP:
-
US pharmacopeia
References
Johnson B (2012) Supply chain security: Pfizer’s approach. http://medxu.com/goc/files/2010/11/Johnson_Global-Complex-Supply-Chain.pdf. Accessed 20 Oct 2012
Rios M (2011) Manufacturing management and analytical strategies for efficient bioprocessing. Bioprocess Int 9(9):10
ICH (2009) Harmonised tripartite guideline, pharmaceutical development Q8(R2). ICH. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf. Accessed 20 Oct 2012
ICH (2005) Harmonised tripartite guideline, quality risk management Q9. ICH. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf. Accessed 20 Oct 2012
ICH (2008) Harmonised tripartite guideline, pharmaceutical quality system Q10. ICH. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf. Accessed 20 Oct 2012
Johnston R, Lambert J, Strump E (2012) An industry perspective on quality by design. Bioprocess Int 10(3):26–35
Vasile C (2000) Handbook of polyolefins 2nd edn. In: Vasile C (ed), Marcel Dekker, Inc., New York. pp 517–560
Vanhamel S, Masy C (2001) Production of disposable bags: a manufacturer’s report. In: Eibl R, Eibl D (eds) Single-use technology in biopharmaceutical manufacture. Wiley, New York, pp 114–134
Altaras GM, Eklund C, Ranucci C, Maheshwari G (2007) Quantitation of interaction of lipids with polymer surfaces in cell culture. Biotechnol Bioeng 96(5):999–1007
Colton R, Sette A, Martin J, St. Laurent j, Hockstad M, Lehman T, Murphy T, Pembleton B, Potheir N, Stover J, Swisher L (2007) Recommendations for extractables and leachabales testing. Part I: introduction. Regulatory issues and risk assessment. Bioprocess Int 5(11):36–44
Colton R, Sette A, Martin J, St. Laurent j, Hockstad M, Lehman T, Murphy T, Pembleton B, Potheir N, Stover J, Swisher L (2008) Recommendations for extractables and leachables testing. Part 2: executing a program. Bioprocess Int 6(1):44–53
Barbaroux M, Sette A (2006) Properties of materials used in single-use flexible containers: requirements and analysis. Biopharm Int pp 18–29. http://www.biopharminternational.com/biopharm/article/articleDetail.jsp?id=423541&sk=&date=&pageID=2. Accessed 20 Oct 2012
Wildemann H (2004) Risikoorientiertes Lieferantenmanagement. Vortrag. In: Materialkostensenkungsseminar, München
Wildemann H (2006) Risikomanagement und Rating, München
Wildemann H (2010) Risikomanagement im Mittelstand, München
Zawisla T (2008) Risikoorientiertes lieferantenmanagement. TCW Transfer-Centrum GmbH & Co. KG, München.
Wieczorek E (2012) Emerging risks a strategic management guide. In: Raimbault C, Barr A, Surrey F (eds) Burlington, Gower
BME, German association of purchasing and supply chain (2012) Prof. Dr. Ralph Schuman, Director contractual management institute, SRH Hochschule, Berlin Beschaffung aktuell 07/08/2012: 28–29
Beck G, Schenerman M, Dougherty J, Cordoba-Rodriguez R, Joneckis C, Mire-Sluis A, McLeod LD (2009) Raw material control strategies for bioprocesses. Bioprocess Int 9:18–33
ISO 9001 (2008) Quality management systems—Requirements.
Global Harmonization Task Force (2008) Quality management system: medical devices—guidance on the control of products and services obtained from Suppliers GHTF/SG3/N17:2008
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Barbaroux, M., Gerighausen, S., Hackel, H. (2013). An Approach to Quality and Security of Supply for Single-Use Bioreactors. In: Eibl, D., Eibl, R. (eds) Disposable Bioreactors II. Advances in Biochemical Engineering/Biotechnology, vol 138. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_2013_198
Download citation
DOI: https://doi.org/10.1007/10_2013_198
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-45157-7
Online ISBN: 978-3-642-45158-4
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)